AdvisorShares Psychedelics Financials
| PSIL Etf | USD 19.11 0.66 3.58% |
Net Expense Ratio 0.0099 | 3 y Sharp Ratio (0.36) |
AdvisorShares | Build AI portfolio with AdvisorShares Etf |
The data published in AdvisorShares Psychedelics' official financial statements typically reflect AdvisorShares Psychedelics' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving AdvisorShares Psychedelics' quantitative information. For example, before you start analyzing numbers published by AdvisorShares accountants, it's essential to understand AdvisorShares Psychedelics' liquidity, profitability, and earnings quality within the context of the AdvisorShares space in which it operates.
AdvisorShares Psychedelics Etf Summary
AdvisorShares Psychedelics competes with Cybin, ATAI Life, and GH Research. The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80 percent of its net assets in securities of companies that derive at least 50 percent of their net revenue from or devote 50 percent of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. Advisorshares Psychedelics is traded on NYSEARCA Exchange in the United States.| Instrument | USA Etf View All |
| Exchange | NYSE ARCA Exchange |
| ISIN | US00768Y3624 |
| CUSIP | 00768Y362 00768Y297 |
| Region | Global |
| Investment Issuer | AdvisorShares |
| Etf Family | AdvisorShares |
| Fund Category | Strategy |
| Portfolio Concentration | Theme |
| Benchmark | Dow Jones Industrial |
| Phone | NA |
| Currency | USD - US Dollar |
AdvisorShares Psychedelics Key Financial Ratios
AdvisorShares Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AdvisorShares Psychedelics's current stock value. Our valuation model uses many indicators to compare AdvisorShares Psychedelics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AdvisorShares Psychedelics competition to find correlations between indicators driving AdvisorShares Psychedelics's intrinsic value. More Info.AdvisorShares Psychedelics ETF is rated number one ETF in beta as compared to similar ETFs. It also is rated number one ETF in one year return as compared to similar ETFs reporting about 147.74 of One Year Return per Beta. Comparative valuation analysis is a catch-all technique that is used if you cannot value AdvisorShares Psychedelics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.AdvisorShares Psychedelics Systematic Risk
AdvisorShares Psychedelics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. AdvisorShares Psychedelics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourty with a total number of output elements of twenty-one. The Beta measures systematic risk based on how returns on AdvisorShares Psychedelics correlated with the market. If Beta is less than 0 AdvisorShares Psychedelics generally moves in the opposite direction as compared to the market. If AdvisorShares Psychedelics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one AdvisorShares Psychedelics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of AdvisorShares Psychedelics is generally in the same direction as the market. If Beta > 1 AdvisorShares Psychedelics moves generally in the same direction as, but more than the movement of the benchmark.
AdvisorShares Psychedelics Thematic Clasifications
AdvisorShares Psychedelics ETF is part of several thematic ideas from Strategy ETFs to Theme ETFs. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasAdvisorShares Psychedelics September 30, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of AdvisorShares Psychedelics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of AdvisorShares Psychedelics ETF. We use our internally-developed statistical techniques to arrive at the intrinsic value of AdvisorShares Psychedelics ETF based on widely used predictive technical indicators. In general, we focus on analyzing AdvisorShares Etf price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build AdvisorShares Psychedelics's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.26 | |||
| Information Ratio | 0.1536 | |||
| Maximum Drawdown | 9.75 | |||
| Value At Risk | (3.54) | |||
| Potential Upside | 3.68 |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in AdvisorShares Psychedelics ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
The market value of AdvisorShares Psychedelics is measured differently than its book value, which is the value of AdvisorShares that is recorded on the company's balance sheet. Investors also form their own opinion of AdvisorShares Psychedelics' value that differs from its market value or its book value, called intrinsic value, which is AdvisorShares Psychedelics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AdvisorShares Psychedelics' market value can be influenced by many factors that don't directly affect AdvisorShares Psychedelics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AdvisorShares Psychedelics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AdvisorShares Psychedelics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AdvisorShares Psychedelics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.